Her2-positive/Low-expression Urinary and Digestive Tract Tumors

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Her2-positive/Low-expression Urinary and Digestive Tract Tumors trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1/2

NCT06031584

A Study of BL-M07D1 in Patients With a Variety of Solid Tumors Including Locally Advanced or Metastatic HER2-positive/Lo…

Phase Ib: Explore the safety and tolerability of BL-M07D1 to further define RP2D in a variety of solid tumors, including locally advanced or metastatic urinary…

China42 participantsStarted 2024-01-19

Treatment: BL-M07D1

Her2-positive/Low-expression Urinary and Digestive Tract Tumors

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Study of BL-M07D1 in Patients With a Variety of Solid Tumors Including Locally Advanced or Metastatic HER2-positive/Lo…

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

A Study of BL-M07D1 in Patients With a Variety of Solid Tumors Including Locally Advanced or Metastatic HER2-positive/Lo…

All recent trials (1 shown)